Facilitatedantibiotictranslocationthrough and - - PowerPoint PPT Presentation
Facilitatedantibiotictranslocationthrough and - - PowerPoint PPT Presentation
Facilitatedantibiotictranslocationthrough and porins K.R.Mahendran,T.Mach,A.Bessonov,H.Weingart,M.Winterhalter JacobsUniversity,Bremen
Outline
- ArtificialBilayermeasurements
- Antibioticentrythroughbacterialporins
OmpF(Cephalosporinsandfluroquinolones) OmpC(Cephalosporinsandfluroquinolones) Omp36(Betalactams)
- Effectoftemperatureonampicillin passage
throughOmpF
- Prospects0 newstructuredevelopment
Motivation
Antibiotic Target
Mainresistancemechanismstodrugs
Yim 2007,modified
Gramnegativebacteria
BacterialPorins
- Specificandnon0specificchannels
- 3majorporins(OmpF,OmpCandPhoE)
- OmpFplaysimportantroleinantibiotictranslocation
OmpF2OMPF OmpC2J1N
Artificiallipidbilayermeasurements
- Electrophysiology
Ionchannels,bacterialporins,toxinsetc
- Currentmeasurement0 Ionflow
- BLMtechniqueallowstoseeinteractionsbetween
antibioticandporinastimeresolvedfluctuationsofion current
- SubstrateinteractingwithPore
canproduce
- Artificiallipidbilayermeasurements
Antibioticinteractswithporinresulting intransientblockageofioniccurrent
CephalosporinspathwaythroughOmpF
- Target:thebacterialcellwall
- Fourthgeneration
Cefpirome+/0 Cefepime+/0
TimeresolvedioncurrentblockagesthroughOmpF
50 100 150 200
- 1
2 3 4 5
OmpFnoantibiotic
time,s current,pA
1 2 3 4 5 50 100 150 200
- time,s
current,pA
OmpF010mMcefepime
1 2 3 4 5 50 100 150 200
time,s current,pA
OmpF05mMcefepime
1 2 3 4 5 50 100 150 200
- time,s
current,pA
OmpF10mMcefpirome
Conditions:1MKCl,pH6,antibioticaddedattransside,V=+50mV
BindingkineticsOmpF0 cefepime
- cisside+50mV
cisside050mV transside+50mV transside050mV IMKClpH6,10mMCefepime
Cefepime(mM) Numberofevents
Singleexponentialfittingofblockagetim ehistogram DwellTim e(m s)
0.5 1 1.5
Count(N)
500 1000
Twoquantitiesaremeasured 1)Numberofblockages 2)Averagetimeofblockage
10mMcefepime Tau=0.12± 0.02ms
At10mMcefepime
Averageresidencetime,Tau=0.12± 0.02ms AssociationrateconstantKon=1868M01s01 DissociationrateconstantKoff=9523.8s01
Antibiotictranslocationisfacilitatedbybindingsiteinthe channel
BindingkineticsOmpF0 cefepime
Microbiologicalassays
Lipidbilayermeasurementscorrelateswithmicrobiologicalassays
meanlysis diameter(mm)
Bredin etal,2002;Vidaletal,2005
PathwayoffluroquinolonesthroughOmpF
- Fluroquinolones0 targetDNA
- Enrofloxacin
- zwitterionic
- Conditions:150mMKCl,pH6,antibioticaddedatcisside,V=0 50mV
- enrofloxacin
Anexampleofstronginteraction0 OmpFand Enrofloxacin
Τau050mV=2.98±0.56msec Τau50mV=1.82±0.4msec
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 300 600 900 1200
50mV 050mV C[Enro],mM
ν,ev/sec
BindingKinetics
Nestorovichetal,2002
Conditions:150mMKCl,pH6 Conditions:1MKCl,pH6
≈10ev/secat3mM,V=50mV ≈20ev/secat3mM,V=050mV ≈65ev/secat3mM,V=50mV ≈720ev/secat3mM,V=050mV
Enrofloxacinblockingevents
Ampicillinblockingevents
AntibiotictranslocationthroughOmpC
Trimerformssmallestfunctionalunit OmpC 60%identityinaminoacidsequencetoOmpF Keyresiduesconserved,differentpositions (Basle2006) Moreacidicresiduesandcation selectivecomparedtoOmpF Liposomeswellingassays(NikaidoandRosenburg1985)
Porin Singlechannel Conductance(nS) 1MKCLpH6 Criticalvoltagefor Channelclosure(mV) Ionicselectivity PK/Cl 204 7030 4 2.5 1000150 2000250
Cefepime0 Fourthgeneration+/0 Ceftriaxone0 Thirdgeneration02 Norfloxacin– Fluroquinolone+/0
AntibiotictranslocationthroughOmpC
OmpF OmpC
TimeresolvedioncurrentblockagesthroughOmpC
OmpCnoantibiotic
1s 50pA
OmpC10mMCefepime
1s 50pA
OMPC10mMCEFTRIOXONE
1s 50pA
OmpC2mMNORFLOXACIN
1s 50pA
Conditions:1MKCl,pH6,antibioticaddedatcis side,V=+100mV
PowerSpectrumOmpC0Norfloxacin
Frequency(Hz)
100 1000 10000
Amplitude(pA²/Hz)
1e04 0.001 0.01 0.1
0mMnorfloxacin 1mMnorfloxacin 2mMnorfloxacin 3mMnorfloxacin
- Determinationofbindingparameters
Determinationofbindingparameters
Residencetime
CefepimeTau0.1± 0.02ms CeftriaxoneTau0.14± 0.02ms Norfloxacin Tau0.2±0.02 Ampicilin nobindingevent
StrengthantibioticinteractionwithOmpC Norfloxacin>ceftriaxone>cefepime>ampicillin
Antibiotictranslocationthrough Omp36
- possessesthreeknownporins
- Omp35( OmpF,OmpK35homolog)
- Omp36(OmpC,OmpK36homolog)
- Omp37
Antibiotics
- Ertapenem,cefepime,ceftazidimeandampicillin
2 4 6 8 10 50 100 150 200 250
- cisside050m
V cisside+50m V transside050m V transside+50m V
Ertapenem concentration,(m M ) Numberofeventspersecond
BindingkineticsOmp36
5 10 15 20 25 5 10 15 20 25 30
- trans0side;
V=050mV cis0side; V=050mV trans0side; V=+50mV cis0side; V=+50mV
ν,s01
cefepime,mM Numberofeventspersecond
BindingkineticsofOmp36
Frequency(Hz)
100 1000 10000
A m p litu d e ( p A ² /H z )
0.001 0.01
10mMertapenem 25mMcefepime Noantibiotic
- cisertapenem
transertapenem cisandtransertapenem
Appliedvoltage,m V Averageresidencetime,ms
Bilayermeasurementscorrelatedwithantibioticactivitiesinbacteria (Chloë E.James) Tauertapenem0.14±0.02ms Taucefepime0.1±0.02ms
Temperatureeffectonantibiotic translocationthroughOmpF
- OmpFhighlystable.
- Newparameter
- OmpFconductancestronglydependsontemperature
- AmpicillinandNorfloxacin(Catalin)
- Temperature (50550C)
2 5 m s 2 5 p A
t i m e , m s current,pA
t i m e , m s current,pA t i m e , m s current,pA
50c 150c 250c
Ioncurrentblockagesatdifferenttemperatures
Opencurrent Closedporecurrent 10mMampicillin,1MKClpH6,+50mV
t i m e , m s currentpA
350c
t i m e , m s current,pA
450c 550c
2 5 m s 2 5 p A
t i m e , m s current,pA
Determinationofbindingparameters
10 20 30 40 50 60 2 4 6 8 10 12
- Temperature(c)
Numberofeventspersecond
10mMAmpicillincisside IMKClpH6+50mV
DependenceofAmpicillin0OmpFbindingeventsontemperature
10 20 30 40 50 60 0.0 0.2 0.4 0.6 0.8 1.0 1.2
- cisside+50mV
transside+50mV 10mMampicillinpH6
Dependenceofresidencetimeontemperature
TemperatureC Residencetime,ms
Chemicalrateconstants(konandkoff)weredetermined Dependsontemperature
Prospects
- Wehavebeenabletomeasuretime0resolvedsingle0 molecule
eventsofantibioticentryintothepore,andobtaindetailedkinetic information. Highresolutionconductancemeasurementscorrelatedwith antibioticactivitiesinbacteria(MICassays) Experimentalresultsfromlipidbilayermeasurements andmicrobiologicalassayscomparedwithmolecular dynamicssimulations. Miniaturation(Nanion) Developmentofnewantibioticswithhightranslocation efficiencyinfuture.
Nestorovichetal,2002